| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. | President, CEO, Director | Employee Stock Option (right to buy) | 562,500 | 10 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | 10 Feb 2026 | 1 | $0 | 4 | President, CEO, Director | 10 Feb 2026, 17:43 |
| NRIX | Nurix Therapeutics, Inc. | 11 Feb 2025 | 1 | $0 | 4 | President, CEO, Director | 13 Feb 2025, 16:12 |
| NRIX | Nurix Therapeutics, Inc. | 13 Feb 2024 | 1 | $0 | 4 | President, CEO, Director | 15 Feb 2024, 07:22 |
| NRIX | Nurix Therapeutics, Inc. | 14 Feb 2023 | 1 | $0 | 4 | President, CEO, Director | 15 Feb 2023, 15:12 |
| NRIX | Nurix Therapeutics, Inc. | 09 Aug 2022 | 1 | $0 | 4 | President, CEO, Director | 10 Aug 2022, 16:16 |
| NRIX | Nurix Therapeutics, Inc. | 20 Jan 2022 | 1 | $0 | 4 | President, CEO, Director | 21 Jan 2022, 15:25 |